PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News: STENTYS (FR0010949404 – STNT) (Paris:STNT), a medical technology company commercializing the world’s first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced that the Self-Apposing stent has been implanted over 10,000 times in patients worldwide. This milestone further illustrates the popularity of STENTYS’ technology among cardiologists in Europe and a growing number of regions globally.
Hey, check out all the research scientist jobs. Post your resume today!
